EGFR and non-small cell lung carcinoma: The Roche cobas EGFR Mutation Test v2 (Roche Molecular Diagnostics, Pleasanton, CA, USA), an RT-PCR test approved by the U.S. Food and Drug Administration as a companion diagnostic tool for EGFR-TKI therapy for advanced non-small cell lung cancer, is the most popular testing platform in Taiwan.